Literature DB >> 758407

Aminoglycoside clearance in patients with cystic fibrosis.

E Finkelstein, K Hall.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 758407     DOI： 10.1016/s0022-3476(79)80394-7

Source DB:  PubMed          Journal:  J Pediatr        ISSN： 0022-3476            Impact factor:   4.406


× No keyword cloud information.
  19 in total

1.  Optimal design for model discrimination and parameter estimation for itraconazole population pharmacokinetics in cystic fibrosis patients.

Authors:  Timothy H Waterhouse; Stefanie Redmann; Stephen B Duffull; John A Eccleston
Journal:  J Pharmacokinet Pharmacodyn       Date:  2005-08       Impact factor: 2.745

Review 2.  Pharmacokinetics of drugs in cystic fibrosis.

Authors:  M Spino
Journal:  Clin Rev Allergy       Date:  1991 Spring-Summer

3.  Sedation with Propofol for Bronchoscopy in Cystic Fibrosis Lung Transplant Recipients.

Authors:  Carrie Ho; Don Hayes; Medhi Khosravi; Mark L Splaingard; Dmitry Tumin; Eric A Lloyd
Journal:  Lung       Date:  2018-05-24       Impact factor: 2.584

Review 4.  Drug disposition in cystic fibrosis.

Authors:  E Rey; J M Tréluyer; G Pons
Journal:  Clin Pharmacokinet       Date:  1998-10       Impact factor: 6.447

5.  Increased renal clearance of cefsulodin due to higher glomerular filtration rate in cystic fibrosis.

Authors:  A Hedman; G Alván; B Strandvik; A Arvidsson
Journal:  Clin Pharmacokinet       Date:  1990-02       Impact factor: 6.447

6.  Influence of the glomerular filtration rate on renal clearance of ceftazidime in cystic fibrosis.

Authors:  A Hedman; Y Adan-Abdi; G Alvan; B Strandvik; A Arvidsson
Journal:  Clin Pharmacokinet       Date:  1988-07       Impact factor: 6.447

Review 7.  Clinical pharmacology of antibiotics and other drugs in cystic fibrosis.

Authors:  J Prandota
Journal:  Drugs       Date:  1988-05       Impact factor: 9.546

8.  Cumulative and acute toxicity of repeated high-dose tobramycin treatment in cystic fibrosis.

Authors:  S S Pedersen; T Jensen; D Osterhammel; P Osterhammel
Journal:  Antimicrob Agents Chemother       Date:  1987-04       Impact factor: 5.191

9.  Pharmacokinetics of amikacin in cystic fibrosis: a study of bronchial diffusion.

Authors:  E Autret; S Marchand; M Breteau; B Grenier
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

10.  Pharmacokinetics of netilmicin in children with and without cystic fibrosis.

Authors:  H Michalsen; T Bergan
Journal:  Antimicrob Agents Chemother       Date:  1981-06       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.